F u n g a l  I n f e c t i o n s
ğŸ¦   F u n g a l  B i o l o g y  a n d  C l a s s i f i c a t i o n
F ungi: Â  Euk ar y otic, het er otr ophic micr oor ganisms Â that digest f ood e x t er nall y  
using h y dr ol y tic enzymes. This e xplains their abilit y t o in v ade blood v essels,  
of t en c ausing hemor r hage in lesions. The y ar e pr imar il y aer obic and synthesiz e  
l ysine via the L î‚ˆÎ± -adipic acid biosynthetic p athwa y . K e y charact er istics include  
chitinous cell walls, er gost er ol-cont aining plasma membranes, 80S r RNA, and  
tubulin-composed micr otubules.
Conidia: Â  Ase xual pr opagules (r epr oductiv e unit s) Â f or med in v ar ious wa ys.
Spor es: Â Can be ase xual or se xual in or igin.
Y e ast s: Â Single-celled fungi r epr oducing b y budding.
Molds: Â Mul ticellular fungi f or ming h yphae (filament s). H yphae c an be sp arsel y  
t o r egular l y sept at e and ha v e a v ar iable number of nuclei.
Dimor phic F ungi: Â Exhibit both y e ast and mold f or ms depending on  
en vir onment al conditions (t emperatur e, CO2, pH, c yst eine le v els).Â  Gr o w as  
y east s or spherules in viv o and at 37Â° C in vitr o, but as molds at 25Â° C.
Classif ic ation b ased on mor phology: Â This is crucial f or identific ation and  
underst anding the pot ential se v er it y of inf ection. Kno wing the dif f er ence  
bet w een y e ast and mold is fundament al. Underst anding dimor phism is  
impor t ant f or underst anding ho w fungi adapt t o dif f er ent en vir onment s (inside  
the bod y vs. out side ).
ğŸ“  C l a s s i f i c a t i o n  o f  F u n g a l  I n f e c t i o n s
F ungal inf ections ar e classified b ased on se v eral f act ors:
1.  Sit e of Inf ection: Â Super ficial, cut aneous, subcut aneous, or syst emic  
( deep ).Â  Syst emic inf ections can spr ead be y ond the initial sit e of inf ection.
2.  R out e of A cquisition: Â Ex ogenous (air bor ne, cut aneous, per cut aneous) or  
endogenous (fr om nor mal flora, e.g.,Â  Candida Â in the GI tract).Â  Endogenous  
inf ections ar e par ticular l y r ele v ant in immunocompr omised individuals.
3 .  Virulence: Â Pr imar y p athogens inf ect he al th y individuals, while oppor tunistic  
p athogens inf ect immunocompr omised host s.Â  Underst anding the host's  
F ungal Inf ections
1immune st atus is cr itical in det er mining the lik elihood and se v er it y of fungal  
inf ection.
Ex amples:
Candida î‚’ Nor mal flora in the GI tract, mouth, and v agina. Candidemia  
î‚Candida in the bloodstr e am) is a ser ious complic ation.
Asper gillus î‚’ Common en vir onment al fungus; c an c ause in v asiv e  
asper gillosis, p ar ticular l y in immunocompr omised individuals.
Hist oplasma capsulatum î‚’ F ound in soil cont aminat ed with bir d or b at  
dr oppings; c auses hist oplasmosis.
ğŸ”¬  D i a g n o s i s  o f  F u n g a l  I n f e c t i o n s
1.  Clinic al Pr esent ation: Â Sympt oms v ar y widel y depending on the fungus and  
sit e of inf ection.Â  A thor ough hist or y , including tr a v el hist or y and under l ying  
medical conditions, is crucial.
2.  Micr oscopic Ex amination: Â Dir ect e xamination of clinic al specimens ( e.g.,  
skin scrapings, tissue biopsies) t o identify fungal element s (h yphae,  
y e ast s).Â  Gr am st aining can be useful f or initial assessment, but specific st ains  
( e.g., P AS, GMSî‚‚ ar e of t en needed f or definitiv e identification.
3 .  Cul tur e: Â Gr o wth of the fungus on selectiv e media ( e.g., Sabouraud de x tr ose  
agar) f or identific ation.Â  Cul tur e is the gold st andar d f or definitiv e diagnosis, but  
can be time-consuming.
4 .  Ser ologic al T est s: Â Det ection of fungal antigens ( e.g., galact omannan  
f orÂ  Asper gillus , 1, 3î‚ˆÎ²-D-gluc an f or man y fungi) or antibodies in serum.Â  These  
t est s can be helpful f or r apid diagnosis, but ma y ha v e limit ations in sensitivit y  
and specificit y .
5 .  Molecular Diagnostics: Â PCR-b ased methods f or rapid and sensitiv e  
det ection of fungal DNA.Â  Molecular diagnostics ar e incr easingl y impor t ant f or  
identifying dif ficul t -t o-cul tur e fungi or f or det ecting r esist ance mut ations.
Impor t ant Not e: Â Cont amination vs. inf ection: FindingÂ  Candida Â in ur ine or  
sputum ma y indic at e cont amination, not inf ection.Â  Candida Â in blood cul tur e is  
alwa ys consider ed an inf ection.
ğŸ’Š  A n t i f u n g a l  T r e a t m e n t
F ungal Inf ections
2Antifungal drugs t ar get v ar ious aspect s of fungal cell biology .Â  T r eatment  
choices depend on the inf ecting fungus, sit e of inf ection, and host f act ors.
Major Classes:
Az oles: Â Inhibit er gost er ol synthesis ( e.g., fluconaz ole, itraconaz ole,  
v or iconaz ole ).
Echinoc andins: Â Inhibit cell wall synthesis ( e.g., c aspofungin, mic afungin,  
anidulafungin).
P ol y enes: Â Bind t o er gost er ol, disrupting membrane int egr it y ( e.g.,  
amphot er icin Bî‚‚.
All y lamines: Â Inhibit squalene epo xidase ( e.g., t er binafine ).
Drug R esist ance: Â  Candida aur is , az ole-r esist antÂ  Asper gillus fumigatus ,  
andÂ  T r ichoph y t on indotineae Â ar e signific ant concer ns due t o their r esist ance t o  
commonl y used antifungal agent s.
S p e c i f i c  F u n g a l  I n f e c t i o n s :  A  P a r e t o  A p p r o a c h
This section f ocuses on high-yield fungal inf ections f or y our e xam.
1.Â  Candida Â Inf ections:
Candidemia: Â  Candida Â in the bloodstr e am; r equir es pr ompt tr e atment with  
echinoc andins ( c aspofungin, anidulafungin) or amphot er icin B. Sour ce  
contr ol ( e.g., r emo v al of intra v enous c athet ers) is crucial.
In v asiv e Candidiasis: Â Can af f ect mul tiple or gans (kidne ys, liv er , lungs,  
CNSî‚‚. Risk f act ors include neutr openia, br o ad-spectrum antibiotic use, and  
indw elling de vices.
Mucocut aneous Candidiasis: Â Oral thrush, esophagitis, vul v o v aginitis.  
T r e atment t ypic all y in v ol v es t opic al or oral az oles.
2.Â  A sper gillus Â Inf ections:
In v asiv e A sper gillosis: Â Se v er e inf ection, p ar ticular l y in  
immunocompr omised individuals. Risk f act ors include neutr openia,  
cor ticost er oids, and hemat opoietic st em cell transplant ation. T r e atment  
in v ol v es v or iconaz ole or other az oles, of t en combined with echinoc andins.
Aller gic Br onchopulmonar y A sper gillosis î‚ABP Aî‚‚î‚’ Â H ypersensitivit y  
r e action in p atient s with asthma. Charact er iz ed b y ele v at ed IgE le v els,  
eosinophilia, and r ecur r ent e xacer b ations.
F ungal Inf ections
33 .  Mucor m y cosis î‚Zy gom y cosis):
Caused b y Mucorales ( e.g.,Â  Rhiz opus ,Â  Mucor ).Â  Char act er iz ed b y br oad,  
r ibbon-lik e h yphae with r ar e sept ations.
Risk f act ors include diabet es mellitus (k et o acidosis), glucocor ticoid use,  
and hemat ologic malignancies.
Of t en pr esent s with r hino-or bit al-cer ebral in v ol v ement, r equir ing  
aggr essiv e sur gic al debr idement and antifungal therap y ( e.g., amphot er icin  
B, posaconaz ole ).
4 .  Hist oplasmosis:
Caused b yÂ  Hist oplasma capsulatum , f ound in soil cont aminat ed with bir d or  
b at dr oppings.
Most inf ections ar e asympt omatic or mild. Se v er e dise ase c an in v ol v e the  
lungs or disseminat e t o other or gans.
T r e atment depends on the se v er it y of the inf ection and ma y in v ol v e  
itraconaz ole or amphot er icin B.
F ungal Inf ections
4